Pharma Focus Asia's newest release explores regulations around Cell and Gene Therapy (CGT), drug development in the JAPAC region, and advances in therapies and biomarkers. It covers sports drug analysis, innovative trial methods, safety in geriatric medicine, AI in pharmacovigilance, and drug delivery systems, highlighting Asia's progress in pharmaceuticals.
In recent years the landscape of clinical trials has undergone a remarkable evolution
CGT stands at the forefront of personalised medicine revolutionising healthcare by modifying patients
Regulatory authorities are critical to the development and commercialisation of drugs as they govern the safety
Albumin is a globular protein soluble in water and coagulable by heat It is found in egg white blood serum milk and other animal
Cocktail nanoparticles are also valuable in imaging applications such as in cancer diagnosis and monitoring
Biological therapy uses the bodys immune system to combat cancer using cells antibodies and organs
Cardiovascular disorders CVDs including peripheral vascular disease
Performance enhancement has featured in sports since ancient times
Clinical research has always been at the forefront of medical advancements
Higher life expectancy among Asian people leads to a high number of elderly aged and over nowadays
The past two decades have witnessed mind blowing progress in concepts strategies as well as technologies
AI with its advanced analytical capabilities has shown promising potential in enhancing pharmacovigilance throughout the drug life
The general trend in manufacturing has been to eliminate intermediate stops between processing steps
Progress in the field of molecular pharmacology and improved understanding of disease pathophysiology